Recombinant human erythropoietin injections for stimulating red blood cell production in anemia. Provided by biotech firms to dialysis units, renal clinics, and general hospitals for acquisition by nephrologists and healthcare administrators treating chronic kidney disease and chemotherapy-induced anemia.